Publications & News

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P Simko, Sandy DeVries, Emmalyn Chen, Edward M Schaeffer, Todd M Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach III, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James Wallace, Michelle J. Ferguson, Jean-Paul Bahary, James Zou, Matthew Lungren, Serena Yeung, Ashley E. Ross, NRG Prostate Cancer AI Consortium, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie Pugh, Felix Y. Feng, Osama Mohamad
This manuscript has been accepted at npj Digital Medicine

Links to Articles & Videos

AI-Derived Digital Pathology-Based Biomarker To Predict the Benefit of ADT in Localized Prostate Cancer – Dan Spratt
An AI biomarker to aid in the decision of treatment with ADT for localized prostate cancer
First Predictive Biomarker for ADT Use in Prostate Cancer Validated
Multimodal AI model superior to standard for prediction of key prostate cancer endpoints
Artificial intelligence-derived biomarker predicts ADT benefit in prostate cancer subset
ASCO GU 2022: An AI-Derived Digital Pathology-Based Biomarker to Predict the Benefit of ADT in Localized Prostate Cancer with Validation in NRG/RTOG 9408

Talks & Interviews About Artera

05/2022 (Osama) -

UTSW Dallas

University of Texas Southwestern Medical Center, Invited visiting professorship


02/2022 (Osama) -

ASCO Genitourinary Cancers Symposium (GU), San Francisco

American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, Annual Meeting


02/2022 (Spratt) -

Zero US too Biomarkers Talk

Largest patient advocacy group in USA


01/2022 (Spratt) -

EAU Section of Oncological Urology (ESOU), Madrid

International invited talk on biomarkers


01/2022 (Spratt) -

Prostate Cancer United Kingdom

Largest funding body for prostate cancer in the UK


12/2021 (Spratt) -

Dana Farber SPORE meeting

NIH funded group of experts in prostate cancer


11/2021 (Spratt) -

Case Comprehensive Cancer Center Artificial Intelligence in Oncology Meeting

One of the largest AI meetings in the USA for Cancer